-
1
-
-
4644288189
-
Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
-
DOI 10.1378/chest.126.3-suppl.338S
-
Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW et al (2004) Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(3 Suppl):338S-400S (Pubitemid 39302602)
-
(2004)
Chest
, vol.126
, Issue.3 SUPPL.
-
-
Geerts, W.H.1
Pineo, G.F.2
Heit, J.A.3
Bergquist, D.4
Lassen, M.R.5
Colwell, C.W.6
Ray, J.G.7
-
2
-
-
0031048661
-
The risk of venous thromboembolism in the orthopedic patient: Epidemiological and physiological data
-
Paiement GD, Mendelsohn C (1997) The risk of venous thromboembolism in the orthopedic patient: epidemiological and physiological data. Orthopedics 20(Suppl):7-9 (Pubitemid 27091856)
-
(1997)
Orthopedics
, vol.20
, Issue.2 SUPPL.
, pp. 7-9
-
-
Paiement, G.D.1
Mendelsohn, C.2
-
3
-
-
33745909893
-
Prevention and treatment of venous thromboembolism. International consensus statement (guidelines according to scientific evidence)
-
Cardiovascular Disease Educational and Research Trust, Cyprus Cardiovascular Disease Educational and Research Trust, European Venous Forum, International Surgical Thrombosis Forum, International Union of Angiology, Union Internationale de Phlébologie
-
Cardiovascular Disease Educational and Research Trust, Cyprus Cardiovascular Disease Educational and Research Trust, European Venous Forum, International Surgical Thrombosis Forum, International Union of Angiology, Union Internationale de Phlébologie (2006) Prevention and treatment of venous thromboembolism. International consensus statement (guidelines according to scientific evidence). Int Angiol 25:101-161
-
(2006)
Int Angiol
, vol.25
, pp. 101-161
-
-
-
4
-
-
60449095843
-
Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery
-
Wolowacz SE, Roskell NS, Maciver F, Beard SM, Robinson PA, Plumb JM et al (2009) Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery. Clin Ther 31(1):194-212
-
(2009)
Clin Ther
, vol.31
, Issue.1
, pp. 194-212
-
-
Wolowacz, S.E.1
Roskell, N.S.2
Maciver, F.3
Beard, S.M.4
Robinson, P.A.5
Plumb, J.M.6
-
5
-
-
45949099359
-
Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty
-
DOI 10.1056/NEJMoa0800374
-
Eriksson BI, Borris LC, Friedman RJ, Haas S, Huisman MV, Kakkar AK, et al (2008) Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 358(26):2765-2775 (Pubitemid 351930851)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.26
, pp. 2765-2775
-
-
Eriksson, B.I.1
Borris, L.C.2
Friedman, R.J.3
Haas, S.4
Huisman, M.V.5
Kakkar, A.K.6
Bandel, T.J.7
Beckmann, H.8
Muehlhofer, E.9
Misselwitz, F.10
Geerts, W.11
-
6
-
-
46049106502
-
Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: A double-blind, randomised controlled trial
-
Elsevier
-
Kakkar AK, Brenner B, Dahl OE, Eriksson BI, Mouret P, Muntz J et al (2008) Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. The Lancet. Elsevier 372(9632):31-39
-
(2008)
The Lancet
, vol.372
, Issue.9632
, pp. 31-39
-
-
Kakkar, A.K.1
Brenner, B.2
Dahl, O.E.3
Eriksson, B.I.4
Mouret, P.5
Muntz, J.6
-
7
-
-
45949103416
-
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty
-
DOI 10.1056/NEJMoa076016
-
Lassen MR, Ageno W, Borris LC, Lieberman JR, Rosencher N, Bandel TJ, et al (2008) Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N. Engl. J. Med 358(26):2776-2786 (Pubitemid 351930852)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.26
, pp. 2776-2786
-
-
Lassen, M.R.1
Ageno, W.2
Borris, L.C.3
Lieberman, J.R.4
Rosencher, N.5
Bandel, T.J.6
Misselwitz, F.7
Turpie, A.G.G.8
-
8
-
-
65549169515
-
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): A randomised trial
-
Turpie AG, Lassen MR, Davidson BL, Bauer KA, Gent M, Kwong LM, et al (2009) Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. The Lancet 373(9676):1673-1680
-
(2009)
The Lancet
, vol.373
, Issue.9676
, pp. 1673-1680
-
-
Turpie, A.G.1
Lassen, M.R.2
Davidson, B.L.3
Bauer, K.A.4
Gent, M.5
Kwong, L.M.6
-
9
-
-
84902369633
-
-
www.nice.org.uk. Cited 28 Feb 2012. Available from
-
National Institute of Clinical Excellence (NICE) (2009) TA170 Venous thromboembolism - rivaroxaban: guidance www.nice.org.uk. Cited 28 Feb 2012. Available from: http://www.nice.org.uk/TA170
-
(2009)
TA170 Venous Thromboembolism - Rivaroxaban: Guidance
-
-
-
10
-
-
77951805898
-
NICE and venous thromboembolism
-
Atkins RM (2010) NICE and venous thromboembolism. J Bone Joint Surg Br 92(5):609-610
-
(2010)
J Bone Joint Surg Br
, vol.92
, Issue.5
, pp. 609-610
-
-
Atkins, R.M.1
-
11
-
-
78651252397
-
Return to theatre following total hip and knee replacement, before and after the introduction of rivaroxaban: A retrospective cohort study
-
Jensen C, Steval A, Partington P, Reed M, Muller S (2011) Return to theatre following total hip and knee replacement, before and after the introduction of rivaroxaban: a retrospective cohort study. J Bone Joint Surg Br 93(1):91
-
(2011)
J Bone Joint Surg Br
, vol.93
, Issue.1
, pp. 91
-
-
Jensen, C.1
Steval, A.2
Partington, P.3
Reed, M.4
Muller, S.5
-
12
-
-
56249146711
-
Rivaroxaban for thromboprophylaxis
-
author reply 2175-3176
-
Lotke PA (2008) Rivaroxaban for thromboprophylaxis. N Engl J Med 359(20):2174; author reply 2175-3176
-
(2008)
N Engl J Med
, vol.359
, Issue.20
, pp. 2174
-
-
Lotke, P.A.1
-
13
-
-
77957575230
-
-
www.guidance.nice.org.uk. Cited 1 Mar 2012. Available from
-
National Intsitute of Clinical Excellence (NICE) (2010) Venous thromboembolism - reducing the risk (CG92) www.guidance.nice.org.uk. Cited 1 Mar 2012. Available from: http://guidance.nice.org.uk/CG92
-
(2010)
Venous Thromboembolism - Reducing the Risk (CG92)
-
-
-
14
-
-
65649111175
-
The incidence of fatal pulmonary embolism after primary hip and knee replacement in a consecutive series of 4253 patients
-
Cusick LA, Beverland DE (2009) The incidence of fatal pulmonary embolism after primary hip and knee replacement in a consecutive series of 4253 patients. J Bone Joint Surg Br 91(5):645-648
-
(2009)
J Bone Joint Surg Br
, vol.91
, Issue.5
, pp. 645-648
-
-
Cusick, L.A.1
Beverland, D.E.2
-
15
-
-
79952496003
-
Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty
-
Turpie AGG, Lassen MR, Eriksson BI, Gent M, Berkowitz SD, Misselwitz F et al (2011) Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Thromb Haemost 105(3):444-453
-
(2011)
Thromb Haemost
, vol.105
, Issue.3
, pp. 444-453
-
-
Turpie, A.G.G.1
Lassen, M.R.2
Eriksson, B.I.3
Gent, M.4
Berkowitz, S.D.5
Misselwitz, F.6
-
16
-
-
33846822062
-
Outcome following deep wound contamination in cemented arthroplasty
-
DOI 10.1007/s00264-006-0121-z
-
Byrne AM, Morris S, McCarthy T, Quinlan W, O'byrne JM (2007) Outcome following deep wound contamination in cemented arthroplasty. Int Orthop 31(1):27-31 (Pubitemid 46208220)
-
(2007)
International Orthopaedics
, vol.31
, Issue.1
, pp. 27-31
-
-
Byrne, A.M.1
Morris, S.2
McCarthy, T.3
Quinlan, W.4
O'Byrne, J.M.5
-
17
-
-
0032723224
-
Outcome of Charnley total hip replacement across a single health region in England: The results at five years from a regional hip register
-
Fender D, Harper WM, Gregg PJ (1999) Outcome of Charnley total hip replacement across a single health region in England: the results at five years from a regional hip register. J Bone Joint Surg Br 81(4):577-581
-
(1999)
J Bone Joint Surg Br
, vol.81
, Issue.4
, pp. 577-581
-
-
Fender, D.1
Harper, W.M.2
Gregg, P.J.3
-
18
-
-
70349923899
-
A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the Irish healthcare setting
-
McCullagh L, Tilson L, Walsh C, Barry M (2009) A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the Irish healthcare setting. Pharmacoeconomics 27(10):829-846
-
(2009)
Pharmacoeconomics
, vol.27
, Issue.10
, pp. 829-846
-
-
McCullagh, L.1
Tilson, L.2
Walsh, C.3
Barry, M.4
-
19
-
-
84902381783
-
XAMOS: A non-interventional study of rivaroxaban in the prophylaxis of venous thromboembolism after hip or knee surgery
-
Turpie A, Jamal W, Schmidt A, Lassen M, Mantovani L, Kreutz R, et al (2011) XAMOS: a non-interventional study of rivaroxaban in the prophylaxis of venous thromboembolism after hip or knee surgery. J Thromb Haemost 9(Suppl 2):961
-
(2011)
J Thromb Haemost
, vol.9
, Issue.SUPPL. 2
, pp. 961
-
-
Turpie, A.1
Jamal, W.2
Schmidt, A.3
Lassen, M.4
Mantovani, L.5
Kreutz, R.6
|